26 February 2009 - Ark Therapeutics Group plc today announces that it has filed a patent application relating to a breakthrough small hairpin RNA (shRNA) based technology that allows both the up- and down-regulation of multiple genes via Ark's existing method of gene delivery.
The details can be read here.
No comments:
Post a Comment